The cell preparation products developed by Sino-Biocan have built a solid solution system for the field of auto-immune cell therapy. Autologous cell therapy, as a cutting-edge technology for disease intervention relying on patients' own immune system cells, has great potential and is expected to be widely used in many key medical fields such as cancer treatment and autoimmune disease control, specifically covering advanced therapeutic means such as CAR-T, TCR-T, TILs and CAR-NK. Sino-Biocan’s products integrate high-precision automated processing technology and rigorous cell processing technology, providing efficient, stable and reliable guarantee for the production process of autologous immune cell therapy, demonstrating its professionalism and responsibility in the field of medical science and technology.

The cell preparation products developed by Sino-Biocan have built a solid solution system for the field of universal immune cell therapy. Universal immune cell therapy uses cells from healthy donors, can be prepared in advance, and can be used in time when patients need it, which greatly reduces the cost of money and time, has broad prospects, significance  and great potential, which is expected to be widely used in many key medical fields such as cancer treatment and autoimmune disease control. It specifically covers UCAR-T, NK cell therapy and other advanced treatment methods. Sino-Biocan's products integrate high-precision automated processing technology and rigorous cell processing technology, providing efficient, stable and reliable guarantee for the production process of universal immune cell therapy, demonstrating its professionalism and responsibility in the field of medical science and technology.

Our cell preparation products provide a comprehensive solution for hematopoietic stem cells that can be efficiently isolated from umbilical cord blood and bone marrow. The solution combines advanced separation technology with automated equipment to ensure high cell purity and activity, providing a reliable source of cells for clinical applications. Through the optimized processing process, Sini-Biocan not only improves the separation efficiency, but also reduces the operational risks and meets the diversified needs of different patients and treatments. Our goal is to provide solid support for hematopoietic stem cell transplantation and related treatments, and to promote the development of regenerative medicine for the benefit of more patients.

The cell preparation products developed by Sino-Biocan can provide concentrated harvesting and packaging solutions for cell gene therapy, focusing on efficient processing of large-volume cell preparations, covering the key links such as concentration, washing and packaging. In addition, the product pipeline of Sino-Biocan can fully meet the diversified needs from low throughput to high throughput preparation packaging, providing solid and reliable production support for the cell gene therapy industry. Through the integration of advanced technology and precision automation equipment, Sino-Biocan strictly ensures the quality and stability of the preparation production process, significantly improves the production efficiency, and effectively reduces the risks caused by human operation. Adhering to a rigorous scientific attitude and a high sense of responsibility, we are committed to providing stable and reliable cell gene therapy solutions to the medical industry, promoting the sustainable development of this field, and bringing more treatment opportunities and hopes to patients.